Citations (214)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Mark Verdecia, John F. Kokai-Kun, Maura Kibbey, Sarita Acharya, Jaap Venema & Fouad Atouf. (2021) COVID-19 vaccine platforms: Delivering on a promise?. Human Vaccines & Immunotherapeutics 17:9, pages 2873-2893.
Read now
Read now
Xiaona Wang, Xinyuan Qiao, Ling Sui, Haiyuan Zhao, Fengsai Li, Yan-Dong Tang, Wen Shi, Yuyao Guo, Yanping Jiang, Li Wang, Han Zhou, Lijie Tang, Yigang Xu & Yijing Li. (2020) Establishment of stable Vero cell lines expressing TMPRSS2 and MSPL: A useful tool for propagating porcine epidemic diarrhea virus in the absence of exogenous trypsin. Virulence 11:1, pages 669-685.
Read now
Read now
Mikhail F. Vorovitch, Karina G. Grishina, Viktor P. Volok, Liubov L. Chernokhaeva, Konstantin V. Grishin, Galina G. Karganova & Aidar A. Ishmukhametov. (2020) Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture. Human Vaccines & Immunotherapeutics 16:9, pages 2123-2130.
Read now
Read now
Xiaofeng Dai, Xuanhao Zhang, Kostya Ostrikov & Levon Abrahamyan. (2020) Host receptors: the key to establishing cells with broad viral tropism for vaccine production. Critical Reviews in Microbiology 46:2, pages 147-168.
Read now
Read now
Franck Touret, Magali Gilles, Raphaelle Klitting, Fabien Aubry, Xavier de Lamballerie & Antoine Nougairède. (2018) Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone. Emerging Microbes & Infections 7:1, pages 1-12.
Read now
Read now
Charles E. Rupprecht, Thirumeni Nagarajan & Hildegund Ertl. (2016) Current Status and Development of Vaccines and Other Biologics for Human Rabies Prevention. Expert Review of Vaccines 15:6, pages 731-749.
Read now
Read now
Nagendra R Hegde. (2015) Cell culture-based influenza vaccines: A necessary and indispensable investment for the future. Human Vaccines & Immunotherapeutics 11:5, pages 1223-1234.
Read now
Read now
Larry R. Smith, Walter Wodal, Brian A. Crowe, Astrid Kerschbaum, Peter Bruehl, Michael G. Schwendinger, Helga Savidis-Dacho, Sean M. Sullivan, Mark Shlapobersky, Jukka Hartikka, Alain Rolland, P. Noel Barrett & Otfried Kistner. (2013) Preclinical evaluation of Vaxfectin®-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines. Human Vaccines & Immunotherapeutics 9:6, pages 1333-1345.
Read now
Read now
P Noel Barrett, Daniel Portsmouth & Hartmut J Ehrlich. (2013) Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development. Expert Review of Vaccines 12:4, pages 395-413.
Read now
Read now
Emanuele Montomoli, Baharak Khadang, Simona Piccirella, Claudia Trombetta, Elisa Mennitto, Ilaria Manini, Valerio Stanzani & Giulia Lapini. (2012) Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production. Expert Review of Vaccines 11:5, pages 587-594.
Read now
Read now
Michael L Perdue, Frank Arnold, Sheng Li, Armen Donabedian, Vittoria Cioce, Thomas Warf & Robert Huebner. (2011) The future of cell culture-based influenza vaccine production. Expert Review of Vaccines 10:8, pages 1183-1194.
Read now
Read now
Selma Calcagnile & Gian Vincenzo Zuccotti. (2010) The virosomal adjuvanted influenza vaccine. Expert Opinion on Biological Therapy 10:2, pages 191-200.
Read now
Read now
Yvonne Genzel & Udo Reichl. (2009) Continuous cell lines as a production system for influenza vaccines. Expert Review of Vaccines 8:12, pages 1681-1692.
Read now
Read now
Articles from other publishers (201)
Surekha SurekhaAnoop KumarHarit KasanaJaipal MeenaArchana Sayal. (2023) Comparative Evaluation of HEP-2(Cincinnati) and Vero cell lines sensitivity to Bivalent Oral Polio Virus Vaccine (Type 1 and Type 3) by using In-vitro Microtitration Potency Assay. Research Journal of Pharmacy and Technology, pages 4719-4722.
Crossref
Crossref
Miao Li, Enyue Fang, Yunpeng Wang, Leitai Shi, Jia Li, Qinhua Peng, Xingxing Li, Danhua Zhao, Xiaohui Liu, Xinyu Liu, Jingjing Liu, Hongshan Xu, Hongyu Wang, Yanqiu Huang, Ren Yang, Guangzhi Yue, Yue Suo, Xiaohong Wu, Shouchun Cao & Yuhua Li. (2023) An mRNA vaccine against rabies provides strong and durable protection in mice. Frontiers in Immunology 14.
Crossref
Crossref
Jie Pei, Rui-Lun Liu, Zhi-Hui Yang, Ya-Xin Du, Sha-Sha Qian, Sheng-Li Meng, Jing Guo, Bo Zhang & Shuo Shen. (2023) Identification of Critical Amino Acids of Coxsackievirus A10 Associated with Cell Tropism and Viral RNA Release during Uncoating. Viruses 15:10, pages 2114.
Crossref
Crossref
Halima Rhazi, Ikram Tifrouin, Karima Mikou, Oumaima Belayadi, Najete Safini, Meryem Alhyane, Khalid Omari Tadlaoui, Matthias Lenk & Mehdi Elharrak. (2023) Poxvirus sensitivity of a novel diploid sheep embryonic heart cell line. Archives of Virology 168:9.
Crossref
Crossref
Annalisa Chianese, Claudia Gravina, Maria Vittoria Morone, Annalisa Ambrosino, Marialuisa Formato, Francesca Palma, Francesco Foglia, Bianca Maria Nastri, Carla Zannella, Assunta Esposito, Anna De Filippis, Simona Piccolella, Massimiliano Galdiero & Severina Pacifico. (2023) Lavandula austroapennina: Assessment of the Antiviral Activity of Lipophilic Extracts from Its Organs. Viruses 15:8, pages 1648.
Crossref
Crossref
Ouyang Peng, Yu Wu, Fangyu Hu, Yu Xia, Rui Geng, Yihui Huang, Siying Zeng, Guangli Hu, Chunyi Xue, Hao Zhang & Yongchang Cao. (2023) Transcriptome Profiling of Vero E6 Cells during Original Parental or Cell-Attenuated Porcine Epidemic Diarrhea Virus Infection. Viruses 15:7, pages 1426.
Crossref
Crossref
Tao Yang, Yingfan Chen, Yajing Xu, Xiangyu Liu, Mingying Yang & Chuanbin Mao. (2023) Viruses as biomaterials. Materials Science and Engineering: R: Reports 153, pages 100715.
Crossref
Crossref
Christopher Ton, Victoria Stabile, Elizabeth Carey, Adam Maraikar, Travis Whitmer, Samantha Marrone, Nelson Lee Afanador, Igor Zabrodin, Greeshma Manomohan, Melissa Whiteman & Carl Hofmann. (2023) Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor. Biotechnology Reports 37, pages e00782.
Crossref
Crossref
Enric Redondo Monte, David O'Neill & Karin M Abitorabi. (2023) A risk assessment study of SARS-CoV-2 propagation in the manufacturing of cellular products. Regenerative Medicine 18:2, pages 169-180.
Crossref
Crossref
Sh. S. Turyskeldi, Zh. Zh. Sametova, A. K. Usembay & Ye. A. Bulatov. (2023) COMPARISON OF THE RESULTS OF CULTURING CELLS AND VIRUSES ON THE NEW SEPLIFE® LX-MC-DEX1 MICROCARRIER WITH EXISTING MICROCARRIERS. Biosafety and Biotechnology:11, pages 13-22.
Crossref
Crossref
Pavel A. Solopov. (2023) COVID-19 Vaccination and Alcohol Consumption: Justification of Risks. Pathogens 12:2, pages 163.
Crossref
Crossref
Orsolya Hamusics & Daniel Loewe. 2023. Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs). Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs)
49
72
.
K. Savina, Rakhy Sreekumar, V. K. Soonu & E. J. Variyar. (2022) Various vaccine platforms in the field of COVID-19. Beni-Suef University Journal of Basic and Applied Sciences 11:1.
Crossref
Crossref
Rajeka Lazarus, Benedicte Querton, Irena Corbic Ramljak, Shailesh Dewasthaly, Juan Carlos Jaramillo, Katrin Dubischar, Michael Krammer, Petronela Weisova, Romana Hochreiter, Susanne Eder-Lingelbach, Christian Taucher, Adam Finn, Claire Bethune, Marta Boffito, Marcin Bula, Fiona M Burns, Rebecca Clark, Dileep Dasyam, Simon Drysdale, Saul Faust, Effrossyni Gkrania-Klotsas, Christopher Green, Hana Hassanin, Paul Heath, Amardeep Heer, Toby Helliwell, Anil Hormis, Philip Kalra, Rajeka Lazarus, Ed Moran, John Ndikum, Iain Page, David Price, Nick Probert, Mahadev Ramjee, Tommy Rampling, Harpal S Randeva, Stephen Ryder, John Steer, Emma Thompson & David Torku. (2022) Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial. The Lancet Infectious Diseases 22:12, pages 1716-1727.
Crossref
Crossref
B. A. Seidakhmetova, G. A. Zhapparova, L. G. Marakhovskaya, A. A. Terebay & A. K. Nakhanov. (2022) SCALING OF VERO CELL CULTURE FOR THE PRODUCTION OF BIOLOGICAL PRODUCTS. Biosafety and Biotechnology:9, pages 44-52.
Crossref
Crossref
Agustín Valenzuela-Fernández, Romina Cabrera-Rodriguez, Laura Ciuffreda, Silvia Perez-Yanes, Judith Estevez-Herrera, Rafaela González-Montelongo, Julia Alcoba-Florez, Rodrigo Trujillo-González, Diego García-Martínez de Artola, Helena Gil-Campesino, Oscar Díez-Gil, José M. Lorenzo-Salazar, Carlos Flores & Jonay Garcia-Luis. (2022) Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Zhanat T. Amanova, Zhanna Zh. Sametova & Yerbol A. Bulatov. (2022) Adaptation of the sheep pox virus (Poxviridae: <i>Capripoxvirus: Sheeppox virus</i>) to African green monkey kidney cell line and evaluation of its immunobiological properties. Problems of Virology 67:5, pages 450-458.
Crossref
Crossref
Shouzhi Yu, Junyu Yan, Zhaona Yang, Yuxiu Zhao, Hui Wang & Xiaoming Yang. (2022) Metabolic Responses and Pathway Changes of Vero Cells under High-Vitamin B Medium. Vaccines 10:11, pages 1787.
Crossref
Crossref
Raquel de M. Barbosa, Amélia M. Silva, Classius F. da Silva, Juliana C. Cardoso, Patricia Severino, Lyghia M. A. Meirelles, Arnobio A. da Silva-Junior, César Viseras, Joel Fonseca & Eliana B. Souto. (2022) Production Technologies, Regulatory Parameters, and Quality Control of Vaccine Vectors for Veterinary Use. Technologies 10:5, pages 109.
Crossref
Crossref
Gabriel Augusto Pires De Souza, Marion Le Bideau, Céline Boschi, Nathalie Wurtz, Philippe Colson, Sarah Aherfi, Christian Devaux & Bernard La Scola. (2022) Choosing a cellular model to study SARS-CoV-2. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Wouter Johannes Petrus van den Braak, Bella Monica, Diana Limpens, Dedeke Rockx-Brouwer, Matthijn de Boer & Dinja Oosterhoff. (2022) Construction of a Vero Cell Line Expressing Human ICAM1 for the Development of Rhinovirus Vaccines. Viruses 14:10, pages 2235.
Crossref
Crossref
Marianna Teixeira de Pinho Favaro, Jan Atienza-Garriga, Carlos Martínez-Torró, Eloi Parladé, Esther Vázquez, José Luis Corchero, Neus Ferrer-Miralles & Antonio Villaverde. (2022) Recombinant vaccines in 2022: a perspective from the cell factory. Microbial Cell Factories 21:1.
Crossref
Crossref
Marie‐Angélique Sène, Yu Xia & Amine A. Kamen. (2022) From functional genomics of vero cells to CRISPR‐based genomic deletion for improved viral production rates. Biotechnology and Bioengineering 119:10, pages 2794-2805.
Crossref
Crossref
Aitor Nogales, Marta L. DeDiego & Luis Martínez-Sobrido. (2022) Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
E. E. Evreinova, L. M. Khantimirova, V. A. Shevtsov, V. A. Merkulov & V. P. Bondarev. (2022) Promising opportunities to improve polio vaccines. Biological Products. Prevention, Diagnosis, Treatment 22:2, pages 142-153.
Crossref
Crossref
Ana C. Alcalá, Martha A. Contreras, Esmeralda Cuevas-Juárez, Octavio T. Ramírez & Laura A. Palomares. (2022) Effect of sericin, a silk derived protein, on the amplification of Zika virus in insect and mammalian cell cultures. Journal of Biotechnology 353, pages 28-35.
Crossref
Crossref
Nica Classen, Diana Ulrich, Arne Hofemeier, Marc Tim Hennies, Wali Hafezi, Aleksandra Pettke, Marie-Luise Romberg, Eva U. Lorentzen, Andreas Hensel & Joachim E. Kühn. (2022) Broadly Applicable, Virus-Free Dual Reporter Assay to Identify Compounds Interfering with Membrane Fusion: Performance for HSV-1 and SARS-CoV-2. Viruses 14:7, pages 1354.
Crossref
Crossref
Marie‐Angélique Sène, Yu Xia & Amine Abdelkader Kamen. (2022) Overview of recent advances in Vero cells genomic characterization and engineering for high‐throughput vaccine manufacturing. Clinical and Translational Discovery 2:2.
Crossref
Crossref
Yaolin Guo, Caiqin Yang, Yongjian Liu, Tianyi Li, Hanping Li, Jingwan Han, Lei Jia, Xiaolin Wang, Bohan Zhang, Jingyun Li & Lin Li. (2022) High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients. Viruses 14:5, pages 996.
Crossref
Crossref
Mohamed Mahdi, Levente Hermán, János M. Réthelyi & Bálint László Bálint. (2022) Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19. International Journal of Molecular Sciences 23:7, pages 3812.
Crossref
Crossref
ChengRui Fei, JingXia Gao, ChengHua Fei, Lei Ma, WenYong Zhu, LingYu He, YaNan Wu, ShaoHui Song, WeiDong Li, Jian Zhou & GuoYang Liao. (2022) A flow-through chromatography purification process for Vero cell-derived influenza virus (H7N9). Journal of Virological Methods 301, pages 114408.
Crossref
Crossref
Anna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, Nandini Prabhakar Venkatesan, Henrik Krarup, Xiangliang Lin, Udo Reichl, Jens Bukh, Yvonne Genzel & Judith Margarete Gottwein. (2022) High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor. Vaccines 10:2, pages 249.
Crossref
Crossref
Xiao Yang, Mingming Wan, Linjun Cai, Ali Hou, Bo Sun, Yan Zhou, Feng Gao, Weiheng Su & Chunlai Jiang. (2021) Interferon Inhibition Enhances the Pilot-Scale Production of Rabies Virus in Human Diploid MRC-5 Cells. Viruses 14:1, pages 49.
Crossref
Crossref
Izabela Fabiańska, Stefan Borutzki, Benjamin Richter, Hon Q. Tran, Andreas Neubert & Dietmar Mayer. (2021) LABRADOR—A Computational Workflow for Virus Detection in High-Throughput Sequencing Data. Viruses 13:12, pages 2541.
Crossref
Crossref
Cristina A. T. Silva, Amine A. Kamen & Olivier Henry. (2021) Recent advances and current challenges in process intensification of cell culture‐based influenza virus vaccine manufacturing. The Canadian Journal of Chemical Engineering 99:11, pages 2525-2535.
Crossref
Crossref
Jitendra Kumar Chaudhary, Rohitash Yadav, Pankaj Kumar Chaudhary, Anurag Maurya, Nimita Kant, Osamah Al Rugaie, Hoineiting Rebecca Haokip, Deepika Yadav, Rakesh Roshan, Ramasare Prasad, Apurva Chatrath, Dharmendra Singh, Neeraj Jain & Puneet Dhamija. (2021) Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Cells 10:11, pages 2949.
Crossref
Crossref
Elad Lerer, Ziv Oren, Yaron Kafri, Yaakov Adar, Einat Toister, Lilach Cherry, Edith Lupu, Arik Monash, Rona Levy, Eyal Dor, Eyal Epstein, Lilach Levin, Meni Girshengorn, Niva Natan, Ran Zichel & Arik Makovitzki. (2021) Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography. BioTech 10:4, pages 22.
Crossref
Crossref
Osnat Rosen, Avital Jayson, Niva Natan, Arik Monash, Meni Girshengorn, Michael Goldvaser, Lilach Levin & Eyal Epstein. (2021) Novel method for quantifying cells on carriers and its demonstration during SARS‐2 vaccine development. Biotechnology and Bioengineering 118:10, pages 3811-3820.
Crossref
Crossref
Marie-Angélique Sène, Sascha Kiesslich, Haig Djambazian, Jiannis Ragoussis, Yu Xia & Amine A. Kamen. (2021) Haplotype-resolved de novo assembly of the Vero cell line genome. npj Vaccines 6:1.
Crossref
Crossref
Raquel Cid & Jorge Bolívar. (2021) Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules 11:8, pages 1072.
Crossref
Crossref
Anna Offersgaard, Carlos Rene Duarte Hernandez, Anne Finne Pihl, Rui Costa, Nandini Prabhakar Venkatesan, Xiangliang Lin, Long Van Pham, Shan Feng, Ulrik Fahnøe, Troels Kasper Høyer Scheel, Santseharay Ramirez, Udo Reichl, Jens Bukh, Yvonne Genzel & Judith Margarete Gottwein. (2021) SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor. Vaccines 9:7, pages 706.
Crossref
Crossref
Fouad A. Abolaban & Fathi M. Djouider. (2021) Gamma irradiation-mediated inactivation of enveloped viruses with conservation of genome integrity: Potential application for SARS-CoV-2 inactivated vaccine development. Open Life Sciences 16:1, pages 558-570.
Crossref
Crossref
Somya Aggarwal, Ebrahim Hassan & Megan T. Baldridge. (2021) Experimental Methods to Study the Pathogenesis of Human Enteric RNA Viruses. Viruses 13:6, pages 975.
Crossref
Crossref
Toshiki Sekiya, Marumi Ohno, Naoki Nomura, Chimuka Handabile, Masashi Shingai, David C. Jackson, Lorena E. Brown & Hiroshi Kida. (2021) Selecting and Using the Appropriate Influenza Vaccine for Each Individual. Viruses 13:6, pages 971.
Crossref
Crossref
Youssef A. Attia, Mohamed T. El-Saadony, Ayman A. Swelum, Shaza Y.A. Qattan, Adel D. Al-qurashi, Khalid A. Asiry, Manal E. Shafi, Ahmed R. Elbestawy, Ahmed R. Gado, Asmaa F. Khafaga, Elsayed O.S. Hussein, Hani Ba-Awadh, Ruchi Tiwari, Kuldeep Dhama, Bakr Alhussaini, Salem R. Alyileili, Khaled A. El-Tarabily & Mohamed E. Abd El-Hack. (2021) COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact—an updated review. Environmental Science and Pollution Research 28:18, pages 22241-22264.
Crossref
Crossref
Yuta Kanai & Takeshi Kobayashi. (2021) Rotavirus reverse genetics systems: Development and application. Virus Research 295, pages 198296.
Crossref
Crossref
Ahd Hamidi, Femke Hoeksema, Pim Velthof, Angelique Lemckert, Gert Gillissen, Alfred Luitjens, Julie E. Bines, Swathi R. Pullagurla, Prashant Kumar, David B. Volkin, Sangeeta B. Joshi, Menzo Havenga, Wilfried A.M. Bakker & Christopher Yallop. (2021) Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine. Vaccine 39:15, pages 2048-2059.
Crossref
Crossref
Yuko Okemoto-Nakamura, Kenji Someya, Toshiyuki Yamaji, Kyoko Saito, Makoto Takeda & Kentaro Hanada. (2021) Poliovirus-nonsusceptible Vero cell line for the World Health Organization global action plan. Scientific Reports 11:1.
Crossref
Crossref
Tetsuro Ikegami. (2021) Development of a Simian RNA Polymerase I Promoter-Driven Reverse Genetics System for the Rescue of Recombinant Rift Valley Fever Virus from Vero Cells. Journal of Virology 95:7.
Crossref
Crossref
Fabienne Piras-Douce, Franck Raynal, Alix Raquin, Yves Girerd-Chambaz, Sylviane Gautheron, Martha Erika Navarro Sanchez, Manuel Vangelisti & Nathalie Mantel. (2021) Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models. Vaccine 39:13, pages 1846-1856.
Crossref
Crossref
Peiyu Han, Xuanhao Zhang, Siming Yang, Xiaofeng Dai, Qing Lv & Dong Hua. (2021) Expanding virus susceptibility spectrum of MDBK cells by expressing host receptors nectin 4 and TfR. Journal of Virological Methods 289, pages 114038.
Crossref
Crossref
Wenwen Xiao, Xunlei Wang, Jing Wang, Puxian Fang, Shaobo Xiao & Liurong Fang. (2021) Replicative capacity of four porcine enteric coronaviruses in LLC-PK1 cells. Archives of Virology 166:3, pages 935-941.
Crossref
Crossref
Muhammad Umer Ashraf, Yeji Kim, Sunil Kumar, Dongyeob Seo, Maryam Ashraf & Yong-Soo Bae. (2021) COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform. Vaccines 9:2, pages 171.
Crossref
Crossref
Alberto A. Amarilla, Naphak Modhiran, Yin Xiang Setoh, Nias Y. G. Peng, Julian D. J. Sng, Benjamin Liang, Christopher L. D. McMillan, Morgan E. Freney, Stacey T. M. Cheung, Keith J. Chappell, Alexander A. Khromykh, Paul R. Young & Daniel Watterson. (2021) An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2. Frontiers in Microbiology 12.
Crossref
Crossref
Xing Liu, Fang Li, Jiwen Zhang, Lulu Wang, Jinliang Wang, Zhiyuan Wen, Zilong Wang, Lei Shuai, Xijun Wang, Jinying Ge, Dongming Zhao & Zhigao Bu. (2021) The ATPase ATP6V1A facilitates rabies virus replication by promoting virion uncoating and interacting with the viral matrix protein. Journal of Biological Chemistry 296, pages 100096.
Crossref
Crossref
Yuta Kanai, Misa Onishi, Takahiro Kawagishi, Pimfhun Pannacha, Jeffery A. Nurdin, Ryotaro Nouda, Moeko Yamasaki, Tina Lusiany, Pattara Khamrin, Shoko Okitsu, Satoshi Hayakawa, Hirotaka Ebina, Hiroshi Ushijima & Takeshi Kobayashi. (2020) Reverse Genetics Approach for Developing Rotavirus Vaccine Candidates Carrying VP4 and VP7 Genes Cloned from Clinical Isolates of Human Rotavirus. Journal of Virology 95:2.
Crossref
Crossref
Laura E. Liao, Jonathan Carruthers, Sophie J. Smither, Simon A. Weller, Diane Williamson, Thomas R. Laws, Isabel García-Dorival, Julian Hiscox, Benjamin P. Holder, Catherine A. A. Beauchemin, Alan S. Perelson, Martín López-García, Grant Lythe, John N. Barr & Carmen Molina-París. (2020) Quantification of Ebola virus replication kinetics in vitro. PLOS Computational Biology 16:11, pages e1008375.
Crossref
Crossref
Sascha Kiesslich & Amine A. Kamen. (2020) Vero cell upstream bioprocess development for the production of viral vectors and vaccines. Biotechnology Advances 44, pages 107608.
Crossref
Crossref
Yun Liao, Xueqi Li, Tangwei Mou, Xiaofang Zhou, Dandan Li, Lichun Wang, Ying Zhang, Xingqi Dong, Huiwen Zheng, Lei Guo, Yan Liang, Guorun Jiang, Shengtao Fan, Xingli Xu, Zhongping Xie, Hongbo Chen, Longding Liu & Qihan Li. (2020) Distinct infection process of SARS‐CoV‐2 in human bronchial epithelial cell lines. Journal of Medical Virology 92:11, pages 2830-2838.
Crossref
Crossref
Randall Alfano, Atherly Pennybaker, Peter Halfmann & Claire Y.‐H. Huang. (2020) Formulation and production of a blood‐free and chemically defined virus production media for VERO cells. Biotechnology and Bioengineering 117:11, pages 3277-3285.
Crossref
Crossref
Phoebe Stevenson-Leggett, Sarah Keep & Erica Bickerton. (2020) Treatment with Exogenous Trypsin Expands In Vitro Cellular Tropism of the Avian Coronavirus Infectious Bronchitis Virus. Viruses 12:10, pages 1102.
Crossref
Crossref
Inmaculada Sanclemente-Alaman, Lidia Moreno-Jiménez, María Soledad Benito-Martín, Alejandro Canales-Aguirre, Jordi A. Matías-Guiu, Jorge Matías-Guiu & Ulises Gómez-Pinedo. (2020) Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2. Frontiers in Immunology 11.
Crossref
Crossref
Kyle V. Todd & Ralph A. Tripp. (2020) Exosome-mediated human norovirus infection. PLOS ONE 15:8, pages e0237044.
Crossref
Crossref
Theresa Kathrina Resch, Yuhuan Wang, Sungsil Moon & Baoming Jiang. (2020)
Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from
In Vitro
and
In Vivo
Studies
. Journal of Virology 94:15.
Crossref
Crossref
Kyle V. Todd & Ralph A. Tripp. (2020) Vero Cells as a Mammalian Cell Substrate for Human Norovirus. Viruses 12:4, pages 439.
Crossref
Crossref
Jianqi Nie, Yang Sun, Fei Han, Yankun Yang, Xiuxia Liu, Chunli Liu, Ye Li & Zhonghu Bai. (2020) Rapid process development of serum-free pseudorabies virus production with the Quality by Design approach. Cytotechnology 72:2, pages 283-293.
Crossref
Crossref
Hoda E. Mohamed, Mervat E. Asker, Nahla S. Kotb & Akram M. El Habab. (2020) Human platelet lysate efficiency, stability, and optimal heparin concentration required in culture of mammalian cells. BLOOD RESEARCH 55:1, pages 35-43.
Crossref
Crossref
Jianqi Nie, Yang Sun, Feng Peng, Xinran Li, Yankun Yang, Xiuxia Liu, Ye Li, Chunli Liu & Zhonghu Bai. (2020) Production Process Development of Pseudorabies Virus Vaccine by Using a Novel Scale-Down Model of a Fixed-Bed Bioreactor. Journal of Pharmaceutical Sciences 109:2, pages 959-965.
Crossref
Crossref
Sascha Kiesslich, José Pedro Vila-Chã Losa, Jean-François Gélinas & Amine A. Kamen. (2020) Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bed. Journal of Biotechnology 310, pages 32-39.
Crossref
Crossref
Deuk-Ki Lee, Jihye Park & Dong-Won Seo. (2020) Suspension culture of Vero cells for the production of adenovirus type 5. Clinical and Experimental Vaccine Research 9:1, pages 48.
Crossref
Crossref
Wern Hann Ng, Xiang Liu & Suresh Mahalingam. (2020) Development of vaccines for SARS-CoV-2. F1000Research 9, pages 991.
Crossref
Crossref
Gheorghe Fundueanu, Marieta Constantin, Sanda Bucatariu, Alina Nicolescu, Paolo Ascenzi, Laura Georgeta Moise, Lavinia Tudor, Violeta Georgeta Trusca, Anca Violeta Gafencu, Denisa Ficai, Anton Ficai & Ecaterina Andronescu. (2020) Simple and dual cross-linked chitosan millicapsules as a particulate support for cell culture. International Journal of Biological Macromolecules 143, pages 200-212.
Crossref
Crossref
Gundappa Saha, Prakash Saudagar & Vikash Kumar Dubey. 2020. Encapsulation of Active Molecules and Their Delivery System. Encapsulation of Active Molecules and Their Delivery System
197
210
.
Thirumeni Nagarajan & Hildegund C.J. Ertl. 2020. Rabies. Rabies
481
508
.
Deborah J. Briggs & Thiravat Hemachudha. 2020. Rabies and Rabies Vaccines. Rabies and Rabies Vaccines
71
82
.
Thirumeni Nagarajan & Charles E. Rupprecht. 2020. Rabies and Rabies Vaccines. Rabies and Rabies Vaccines
11
43
.
Martin Michaelis, Malte C. Kleinschmidt, Denisa Bojkova, Holger F. Rabenau, Mark N. Wass & Jindrich Cinatl Jr.. (2019) Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2. Frontiers in Microbiology 10.
Crossref
Crossref
Xinran Li, Yankun Yang, Rongbin Wang, Guoqiang Liu, Xiuxia Liu, Chunli Liu, Yu Deng & Zhonghu Bai. (2019) Quality by Design-Driven Process Development of Severe Fever With Thrombocytopenia Syndrome Vaccine. Journal of Pharmaceutical Sciences 108:12, pages 3785-3791.
Crossref
Crossref
Nichole Orr-Burks, Jackelyn Murray, Weilin Wu, Carl D. Kirkwood, Kyle V. Todd, Les Jones, Abhijeet Bakre, Houping Wang, Baoming Jiang & Ralph A. Tripp. (2019) Gene-edited vero cells as rotavirus vaccine substrates. Vaccine: X 3, pages 100045.
Crossref
Crossref
Marcos Sousa, Christel Fenge, Jens Rupprecht, Alexander Tappe, Gerhard Greller, Paula Alves, Manuel Carrondo & António Roldão. (2019) Process intensification for Peste des Petites Ruminants Virus vaccine production. Vaccine 37:47, pages 7041-7051.
Crossref
Crossref
Samia Rourou, Meriem Ben Zakkour & Héla Kallel. (2019) Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media. Vaccine 37:47, pages 6987-6995.
Crossref
Crossref
Jenn-Fa Liou, Wen-Ren Wu, Lih-Ren Chen & Yow-Ling Shiue. (2019) Establishment of an induced pluripotent cell line from Taiwan black silkie chick embryonic fibroblasts for replication-incompetent virus production. Scientific Reports 9:1.
Crossref
Crossref
Sophie Buffin, Isabelle Peubez, Fabienne Barrière, Marie-Claire Nicolaï, Tenekua Tapia, Vipra Dhir, Eric Forma, Nicolas Sève & Isabelle Legastelois. (2019) Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies. Vaccine 37:46, pages 6857-6867.
Crossref
Crossref
Sorour Derakhti, Seyed Hamid Safiabadi-Tali, Ghassem Amoabediny & Mojgan Sheikhpour. (2019) Attachment and detachment strategies in microcarrier-based cell culture technology: A comprehensive review. Materials Science and Engineering: C 103, pages 109782.
Crossref
Crossref
Arun S. Annamalai, Aryamav Pattnaik, Bikash R. Sahoo, Zack P. Guinn, Brianna L. Bullard, Eric A. Weaver, David Steffen, Sathish Kumar Natarajan, Thomas M. Petro & Asit K. Pattnaik. (2019) An Attenuated Zika Virus Encoding Non-Glycosylated Envelope (E) and Non-Structural Protein 1 (NS1) Confers Complete Protection against Lethal Challenge in a Mouse Model. Vaccines 7:3, pages 112.
Crossref
Crossref
Noor Fahitah Abu Hanipah, Noor Farah Omar Ahmad, Minaketan Tripathy, Elena Gureeva, Michail Novikov, Yulia Gushchina, Olga Butranova, Nafeeza Hj Mohd Ismail, Seok Mui Wang & Anna Krasilnikova. (2019) Determination of potential solvents for novel N-substituted 5-(phenylamino)uracil derivatives and evaluation of their cytotoxic effects on Vero 76 Cells. Asia Pacific Journal of Molecular Biology and Biotechnology, pages 19-29.
Crossref
Crossref
Aidin Molouki & Abdou Nagy. (2019) Rescue of recombinant Newcastle disease virus: a promising vector with two decades of intensive vaccine research. Future Virology 14:9, pages 617-628.
Crossref
Crossref
Xinran Li, Xuerong Liu, Rongbin Wang, Fanglan An, Jianqi Nie, Yunde Zhang, Hadji Ahamada, Xiuxia Liu, Chunli Liu, Yu Deng, Yankun Yang & Zhonghu Bai. (2019) Quality by Design-Driven Process Development of Cell Culture in Bioreactor for the Production of Foot-And-Mouth Veterinary Vaccine. Journal of Pharmaceutical Sciences 108:7, pages 2288-2295.
Crossref
Crossref
Nancy Elena Guzmán-Delgado, Irma Edith Carranza-Torres, Sara García-Davis, Gildardo Rivera, Javier Morán-Martínez, Nadia Denys Betancourt-Martínez, G. M. M. Groothuis, I. A. M. de Graaf & Pilar Carranza-Rosales. (2019) Development of a Novel Ex-vivo 3D Model to Screen Amoebicidal Activity on Infected Tissue. Scientific Reports 9:1.
Crossref
Crossref
Haruhiko Murata, Romelda Omeir, Wei Tu, Lynda Lanning, Kathryn Phy, Gideon Foseh, Andrew M. LewisJr.Jr. & Keith Peden. (2019) Responsiveness to basement membrane extract as a possible trait for tumorigenicity characterization. Vaccine: X 1, pages 100004.
Crossref
Crossref
Pilar Blanco-Lobo, Aitor Nogales, Laura Rodríguez & Luis Martínez-Sobrido. (2019) Novel Approaches for The Development of Live Attenuated Influenza Vaccines. Viruses 11:2, pages 190.
Crossref
Crossref
Hanns-Joachim Rziha, Mathias Büttner, Melanie Müller, Ferdinand Salomon, Alena Reguzova, Dominic Laible & Ralf Amann. (2019) Genomic Characterization of Orf Virus Strain D1701-V (Parapoxvirus) and Development of Novel Sites for Multiple Transgene Expression. Viruses 11:2, pages 127.
Crossref
Crossref
Marziye Mirbagheri, Vahid Adibnia, Bethany R. Hughes, Stephen D. Waldman, Xavier Banquy & Dae Kun Hwang. (2019) Advanced cell culture platforms: a growing quest for emulating natural tissues. Materials Horizons 6:1, pages 45-71.
Crossref
Crossref
AnakkathilBalan Sudeep, PratikB Vyas, Deepti Parashar & Pratip Shil. (2019) Differential susceptibility & replication potential of Vero E6, BHK-21, RD, A-549, C6/36 cells & Aedes aegypti mosquitoes to three strains of chikungunya virus. Indian Journal of Medical Research 149:6, pages 771.
Crossref
Crossref
Marko Ušaj, Lilach Zattelman, Ronit Regev, Boris I. Shneyer, Naama Wiesel-Motiuk & Arnon Henn. (2018) Overexpression and purification of human myosins from transiently and stably transfected suspension adapted HEK293SF-3F6 cells. Analytical Biochemistry 558, pages 19-27.
Crossref
Crossref
Noam Cohen, Einat Toister, Yonatan Lati, Meni Girshengorn, Lilach Levin, Lea Silberstein, Dror Seliktar & Eyal Epstein. (2018) Cell encapsulation utilizing PEG-fibrinogen hydrogel supports viability and enhances productivity under stress conditions. Cytotechnology 70:3, pages 1075-1083.
Crossref
Crossref
F. Hoeksema, J. Karpilow, A. Luitjens, F. Lagerwerf, M. Havenga, M. Groothuizen, G. Gillissen, A.A.C. Lemckert, B. Jiang, R.A. Tripp & C. Yallop. (2018) Enhancing viral vaccine production using engineered knockout vero cell lines – A second look. Vaccine 36:16, pages 2093-2103.
Crossref
Crossref
Yonatan Levinson, Rajesh G. Beri, Kathryn Holderness, Inbar Friedrich Ben-Nun, Yaling Shi & Eytan Abraham. (2018) Bespoke cell therapy manufacturing platforms. Biochemical Engineering Journal 132, pages 262-269.
Crossref
Crossref
Brendon Y. ChuaToshiki SekiyaDavid C. Jackson. (2018) Opinion: Making Inactivated and Subunit-Based Vaccines Work. Viral Immunology 31:2, pages 150-158.
Crossref
Crossref
Min-Yuan Chia, Wan-Yu Chung, Chun-Hsiung Wang, Wei-Hau Chang & Min-Shi Lee. (2018) Development of a high-growth enterovirus 71 vaccine candidate inducing cross-reactive neutralizing antibody responses. Vaccine 36:9, pages 1167-1173.
Crossref
Crossref
Matthias GromeierSmita K. Nair. (2018) Recombinant Poliovirus for Cancer Immunotherapy. Annual Review of Medicine 69:1, pages 289-299.
Crossref
Crossref
Joshua Powell & Timothy Straub. (2018) Advances and Remaining Challenges in the Study of Influenza and Anthrax Infection in Lung Cell Culture. Challenges 9:1, pages 2.
Crossref
Crossref
Chisato Sakuma, Tsuyoshi Sekizuka, Makoto Kuroda, Fumio Kasai, Kyoko Saito, Masaki Ikeda, Toshiyuki Yamaji, Naoki Osada & Kentaro Hanada. (2018) Novel endogenous simian retroviral integrations in Vero cells: implications for quality control of a human vaccine cell substrate. Scientific Reports 8:1.
Crossref
Crossref
Hari Pujar & Mats Lundgren. 2018. Biopharmaceutical Processing. Biopharmaceutical Processing
877
898
.
Jackelyn Murray, Kyle V. Todd, Abhijeet Bakre, Nichole Orr-Burks, Les Jones, Weilin Wu & Ralph A. Tripp. (2017) A universal mammalian vaccine cell line substrate. PLOS ONE 12:11, pages e0188333.
Crossref
Crossref
Eunbi Yi, Jinsoo Oh, Ngoc Q. Giao, Soohwan Oh & Se-Ho Park. (2017) Enhanced production of enveloped viruses in BST-2-deficient cell lines. Biotechnology and Bioengineering 114:10, pages 2289-2297.
Crossref
Crossref
Miguel G. Toscano, Jeroen van der Velden, Sybrand van der Werf, Machteld Odijk, Ana Roque, Rafael J. Camacho-Garcia, Irene G. Herrera-Gomez, Irene Mancini & Peter de Haan. (2017) Generation of a Vero-Based Packaging Cell Line to Produce SV40 Gene Delivery Vectors for Use in Clinical Gene Therapy Studies. Molecular Therapy - Methods & Clinical Development 6, pages 124-134.
Crossref
Crossref
Ilaria Manini, Claudia Trombetta, Giacomo Lazzeri, Teresa Pozzi, Stefania Rossi & Emanuele Montomoli. (2017) Egg-Independent Influenza Vaccines and Vaccine Candidates. Vaccines 5:3, pages 18.
Crossref
Crossref
Minna M. Hankaniemi, Olli H. Laitinen, Virginia M. Stone, Amirbabak Sioofy-Khojine, Juha A.E. Määttä, Pär G. Larsson, Varpu Marjomäki, Heikki Hyöty, Malin Flodström-Tullberg & Vesa P. Hytönen. (2017) Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model. Vaccine 35:30, pages 3718-3725.
Crossref
Crossref
Weilin Wu, Nichole Orr-Burks, Jon Karpilow & Ralph A. Tripp. (2017) Development of improved vaccine cell lines against rotavirus. Scientific Data 4:1.
Crossref
Crossref
Shuchang Liu, Ludmila Ruban, Yaohe Wang, Yuhong Zhou & Darren N. Nesbeth. (2017) Establishing elements of a synthetic biology platform for Vaccinia virus production: BioBrick™ design, serum-free virus production and microcarrier-based cultivation of CV-1 cells. Heliyon 3:2, pages e00238.
Crossref
Crossref
Ilseob Lee, Jin Il Kim, Sehee Park, Joon-Yong Bae, Kirim Yoo, Soo-Hyeon Yun, Joo-Yeon Lee, Kisoon Kim, Chun Kang & Man-Seong Park. (2017) Single PA mutation as a high yield determinant of avian influenza vaccines. Scientific Reports 7:1.
Crossref
Crossref
A. Roldão, A.C. Silva, M.C.M. Mellado, P.M. Alves & M.J.T. Carrondo. 2017. Comprehensive Biotechnology. Comprehensive Biotechnology
633
656
.
K.M. Coombs. 2017. Comprehensive Biotechnology. Comprehensive Biotechnology
372
382
.
M. Butler & U. Reichl. 2021. Advances in Glycobiotechnology. Advances in Glycobiotechnology
1
36
.
Konstantin A. Tsetsarkin, Heather Kenney, Rubing Chen, Guangping Liu, Hasmik Manukyan, Stephen S. Whitehead, Majid Laassri, Konstantin Chumakov & Alexander G. Pletnev. (2016) A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic in Brazil as a Genetic Platform for Studies of Virus-Host Interactions and Vaccine Development. mBio 7:4.
Crossref
Crossref
Madhuri Gokumakulapalle & Ya-Fang Mei. (2016) Replication-competent human adenovirus 11p vectors can propagate in Vero cells. Virology 495, pages 42-51.
Crossref
Crossref
Asako Murayama, Nao Sugiyama, Takaji Wakita & Takanobu Kato. (2016) Completion of the Entire Hepatitis C Virus Life Cycle in Vero Cells Derived from Monkey Kidney. mBio 7:3.
Crossref
Crossref
Muhammad Asif Zahoor, Mohsin Khurshid, Rabia Qureshi, Aneeqa Naz & Muhammad Shahid. (2016) Cell culture-based viral vaccines: current status and future prospects. Future Virology 11:7, pages 549-562.
Crossref
Crossref
Emily C. Leibovitch & Steven Jacobson. (2016) Vaccinations for Neuroinfectious Disease: A Global Health Priority. Neurotherapeutics 13:3, pages 562-570.
Crossref
Crossref
Jae-Min Song. (2016) Advances in novel influenza vaccines: a patent review. Journal of Microbiology 54:6, pages 403-412.
Crossref
Crossref
Hitomi Fukumoto, Tsunekazu Hishima, Hideki Hasegawa, Hidehisa Saeki, Makoto Kuroda & Harutaka Katano. (2016) Evaluation of Vero-cell-derived simian endogenous retrovirus infection in humans by detection of viral genome in clinicopathological samples and commercialized vaccines and by serology of Japanese general population. Vaccine 34:24, pages 2700-2706.
Crossref
Crossref
Murielle André, Sylviane Reghin, Estelle Boussard, Laurent Lempereur & Stéphane Maisonneuve. (2016) Universal real-time PCR assay for quantitation and size evaluation of residual cell DNA in human viral vaccines. Biologicals 44:3, pages 139-149.
Crossref
Crossref
Teng Ma, Ang-Chen Tsai & Yijun Liu. (2016) Biomanufacturing of human mesenchymal stem cells in cell therapy: Influence of microenvironment on scalable expansion in bioreactors. Biochemical Engineering Journal 108, pages 44-50.
Crossref
Crossref
Mandy Bachmann, Theresa Breitwieser, Christoph Lipps, Dagmar Wirth, Ingo Jordan, Udo Reichl & Timo Frensing. (2016) Impaired antiviral response of adenovirus-transformed cell lines supports virus replication. Journal of General Virology 97:2, pages 293-298.
Crossref
Crossref
Hong Zhang, Qinglin Han, Xianqiang Ping, Li Li, Chong Chang, Ze Chen, Yuelong Shu, Ke Xu & Bing Sun. (2015) A single NS2 mutation of K86R promotes PR8 vaccine donor virus growth in Vero cells. Virology 482, pages 32-40.
Crossref
Crossref
Yvonne E. Thomassen & Wilfried A.M. Bakker. (2015) sIPV process development for costs reduction. Vaccine 33:35, pages 4307-4312.
Crossref
Crossref
Florian Krammer. (2015) Emerging influenza viruses and the prospect of a universal influenza virus vaccine. Biotechnology Journal 10:5, pages 690-701.
Crossref
Crossref
Haruka Momose, Takuo Mizukami, Madoka Kuramitsu, Kazuya Takizawa, Atsuko Masumi, Kumiko Araki, Keiko Furuhata, Kazunari Yamaguchi & Isao Hamaguchi. (2015) Establishment of a New Quality Control and Vaccine Safety Test for Influenza Vaccines and Adjuvants Using Gene Expression Profiling. PLOS ONE 10:4, pages e0124392.
Crossref
Crossref
Otto-Wilhelm Merten. (2015) Advances in cell culture: anchorage dependence. Philosophical Transactions of the Royal Society B: Biological Sciences 370:1661, pages 20140040.
Crossref
Crossref
Amy B. Papaneri, John G. Bernbaum, Joseph E. Blaney, Peter B. Jahrling, Matthias J. Schnell & Reed F. Johnson. (2015) Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine. Virus Research 197, pages 54-58.
Crossref
Crossref
Stephen S. Whitehead, José Bustos-Arriaga, Cai-Yen Firestone & Gregory D. Gromowski. (2015) Genetic and Phenotypic Properties of Vero Cell-Adapted Japanese Encephalitis Virus SA14-14-2 Vaccine Strain Variants and a Recombinant Clone, Which Demonstrates Attenuation and Immunogenicity in Mice. The American Journal of Tropical Medicine and Hygiene 92:1, pages 98-107.
Crossref
Crossref
Ernest Milián & Amine A. Kamen. (2015) Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines. BioMed Research International 2015, pages 1-11.
Crossref
Crossref
Dinja Oosterhoff, Gerard van de Weerd, Gerco van Eikenhorst, Tanja D. de Gruijl, Leo A. van der Pol & Wilfried A. M. Bakker. (2015) Hematopoietic Cancer Cell Lines Can Support Replication of Sabin Poliovirus Type 1. BioMed Research International 2015, pages 1-11.
Crossref
Crossref
Weibin Hu, Hong Zhang, Qinglin Han, Li Li, Yixin Chen, Ningshao Xia, Ze Chen, Yuelong Shu, Ke Xu & Bing Sun. (2015) A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages. Vaccine 33:2, pages 374-381.
Crossref
Crossref
Barbara Sanders, Martin Koldijk & Hanneke Schuitemaker. 2015. Vaccine Analysis: Strategies, Principles, and Control. Vaccine Analysis: Strategies, Principles, and Control
45
80
.
Ana Carina Silva, António Roldão, Ana Teixeira, Paulo Fernandes, Marcos F. Q. Sousa & Paula M. Alves. 2015. Animal Cell Culture. Animal Cell Culture
541
563
.
Naoki Osada, Arihiro Kohara, Toshiyuki Yamaji, Noriko Hirayama, Fumio Kasai, Tsuyoshi Sekizuka, Makoto Kuroda & Kentaro Hanada. (2014) The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell Line. DNA Research 21:6, pages 673-683.
Crossref
Crossref
Emily P. Wen, Ronald Ellis & Narahari S. PujarNarahari S. Pujar, Sangeetha L. Sagar & Ann L. Lee. 2014. Vaccine Development and Manufacturing. Vaccine Development and Manufacturing
1
24
.
Belete Teferedegne, Juliete Macauley, Gideon Foseh, Eugenia Dragunsky, Konstantin Chumakov, Haruhiko Murata, Keith Peden & Andrew M. LewisJr.Jr.. (2014) MicroRNAs as potential biomarkers for VERO cell tumorigenicity. Vaccine 32:37, pages 4799-4805.
Crossref
Crossref
Benedict R. Halbroth, Alexander Heil, Eva Distler, Martin Dass, Eva M. Wagner, Bodo Plachter, Hans Christian Probst, Dennis Strand, Udo F. Hartwig, Anita Karner, Gerald Aichinger, Otfried Kistner, Katharina Landfester & Wolfgang Herr. (2014) Superior In Vitro Stimulation of Human CD8+ T-Cells by Whole Virus versus Split Virus Influenza Vaccines. PLoS ONE 9:7, pages e103392.
Crossref
Crossref
Otto‐Wilhelm Merten, Wilfried A.M. Bakker, Jürgen Vorlop, Manfred Reiter, Gabriel Visnovsky, Volker Jäger, Maia Merabishvili & Uda Reichl. 2014. Industrial Scale Suspension Culture of Living Cells. Industrial Scale Suspension Culture of Living Cells
503
554
.
Manfred Reiter, Daniel Portsmouth & P. Noel Barrett. 2014. Industrial Scale Suspension Culture of Living Cells. Industrial Scale Suspension Culture of Living Cells
390
409
.
A. Aarnink, B. Jacquelin, A. Dauba, S. Hébrard, E. Moureaux, M. Müller-Trutwin & A. Blancher. (2014) MHC polymorphism in Caribbean African green monkeys. Immunogenetics 66:6, pages 353-360.
Crossref
Crossref
Yvonne E. Thomassen, Olaf Rubingh, René H. Wijffels, Leo A. van der Pol & Wilfried A.M. Bakker. (2014) Improved poliovirus d-antigen yields by application of different Vero cell cultivation methods. Vaccine 32:24, pages 2782-2788.
Crossref
Crossref
Alain Pralong, Howard L. Levine, Jan Lilja, Åsa Gaasvik & Hans Hummel. (2014) Paradigm shift for vaccine manufacturing facilities: The next generation of flexible, modular facilities. Engineering in Life Sciences 14:3, pages 244-253.
Crossref
Crossref
Otto-Wilhelm Merten, Matthias Schweizer, Parminder Chahal & Amine A Kamen. (2014) Manufacturing of viral vectors for gene therapy: part I. Upstream processing. Pharmaceutical Bioprocessing 2:2, pages 183-203.
Crossref
Crossref
Pei Xu, Zhenhai Chen, Shannon Phan, Adrian Pickar & Biao He. (2014) Immunogenicity of Novel Mumps Vaccine Candidates Generated by Genetic Modification. Journal of Virology 88:5, pages 2600-2610.
Crossref
Crossref
Andrew W Hudacek, Fetweh H Al-Saleem, Mallory Willet, Travis Eisemann, Jeffrey A Mattis, Lance L Simpson & Matthias J Schnell. (2014) Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo. Molecular Therapy - Methods & Clinical Development 1, pages 14046.
Crossref
Crossref
T ANAND, B C BERA, RIYESH T, R K VAID, S BARUA, NITIN VIRMANI, PRAVEEN MALIK, D KUMAR, P S YADAV & R K SINGH. (2013) Cytopathogenicity of buffalopox and camelpox virus in buffalo fibroblast cells. The Indian Journal of Animal Sciences 83:12.
Crossref
Crossref
Xiaojun Li, Peihu Fan, Jun Jin, Weiheng Su, Dong An, Lin Xu, Shiyang Sun, Yan Zhang, Xiangyu Meng, Feng Gao, Wei Kong & Chunlai Jiang. (2013) Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virology Journal 10:1.
Crossref
Crossref
Zheng Teng, Xiaozhou Kuang, Jiayu Wang & Xi Zhang. (2013) Real-time cell analysis – A new method for dynamic, quantitative measurement of infectious viruses and antiserum neutralizing activity. Journal of Virological Methods 193:2, pages 364-370.
Crossref
Crossref
Klaus Stöhr. 2013. Textbook of Influenza. Textbook of Influenza
352
370
.
Min-Suk Song, Yun Hee Baek, Philippe Noriel Q. Pascua, Hyeok-il Kwon, Su-Jin Park, Eun-Ha Kim, Gyo-Jin Lim & Young-Ki Choi. (2013) Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production. Journal of General Virology 94:6, pages 1230-1235.
Crossref
Crossref
Xuan Shen, Xiaomu Chen, David E. Tabor, Yi Liu, Methal Albarghouthi, Yi-Fan Zhang & Mark S. Galinski. (2013) Size analysis of residual host cell DNA in cell culture-produced vaccines by capillary gel electrophoresis. Biologicals 41:3, pages 201-208.
Crossref
Crossref
P. Noel Barrett, Daniel Portsmouth & Hartmut J. Ehrlich. 2013. Modern Biopharmaceuticals. Modern Biopharmaceuticals
349
386
.
Yu.M. Efremov, A.A. Dokrunova, D.V. Bagrov, K.S. Kudryashova, O.S. Sokolova & K.V. Shaitan. (2013) The effects of confluency on cell mechanical properties. Journal of Biomechanics 46:6, pages 1081-1087.
Crossref
Crossref
Yvonne Genzel, Timo Frensing & Udo Reichl. (2012) Herstellung moderner Grippeimpfstoffe. Chemie in unserer Zeit 47:1, pages 12-22.
Crossref
Crossref
Ilseob LeeJin Il KimMan-Seong Park. (2013) Cell Culture-based Influenza Vaccines as Alternatives to Egg-based Vaccines. Journal of Bacteriology and Virology 43:1, pages 9.
Crossref
Crossref
Julia Hütter, Jana V. Rödig, Dirk Höper, Peter H. Seeberger, Udo Reichl, Erdmann Rapp & Bernd Lepenies. (2013)
Toward Animal Cell Culture–Based Influenza Vaccine Design: Viral Hemagglutinin
N-
Glycosylation Markedly Impacts Immunogenicity
. The Journal of Immunology 190:1, pages 220-230.
Crossref
Crossref
Alaina J Mooney & S Mark Tompkins. (2013) Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses. Future Virology 8:1, pages 25-41.
Crossref
Crossref
Barbara P. Sanders, Diana Edo-Matas, Jerome H.H.V. Custers, Martin H. Koldijk, Vincent Klaren, Marije Turk, Alfred Luitjens, Wilfried A.M. Bakker, Fons Uytdehaag, Jaap Goudsmit, John A. Lewis & Hanneke Schuitemaker. (2013) PER.C6® cells as a serum-free suspension cell platform for the production of high titer poliovirus: A potential low cost of goods option for world supply of inactivated poliovirus vaccine. Vaccine 31:5, pages 850-856.
Crossref
Crossref
Gillian M. Keating, Greg L. Plosker & Katherine A. Lyseng-Williamson. (2012) A/H5N1 Prepandemic Influenza Vaccine (Vepacel®): A Guide to Its Use. BioDrugs 26:6, pages 425-430.
Crossref
Crossref
Greg L. Plosker. (2012) A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel®]. Drugs 72:11, pages 1543-1557.
Crossref
Crossref
Walter Wodal, Falko G. Falkner, Astrid Kerschbaum, Claudia Gaiswinkler, Richard Fritz, Stefan Kiermayr, Daniel Portsmouth, Helga Savidis-Dacho, Sogue Coulibaly, Christina Piskernik, Christine Hohenadl, M. Keith Howard, Otfried Kistner, P. Noel Barrett & Thomas R. Kreil. (2012) A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate. Vaccine 30:31, pages 4625-4631.
Crossref
Crossref
Hartmut J. Ehrlich, Gregory Berezuk, Sandor Fritsch, Gerald Aichinger, Julia Singer, Daniel Portsmouth, Mary Kate Hart, Wael El-Amin, Otfried Kistner & P. Noel Barrett. (2012) Clinical development of a Vero cell culture-derived seasonal influenza vaccine. Vaccine 30:29, pages 4377-4386.
Crossref
Crossref
Jessica O. Josefsberg & Barry Buckland. (2012) Vaccine process technology. Biotechnology and Bioengineering 109:6, pages 1443-1460.
Crossref
Crossref
Timo Vesikari, Stan L. Block, Fernando Guerra, Maria Lattanzi, Sandra Holmes, Allen Izu, Nicolaos Gaitatzis, Anne Katrin Hilbert & Nicola Groth. (2012) Immunogenicity, Safety and Reactogenicity of a Mammalian Cell-Culture–Derived Influenza Vaccine in Healthy Children and Adolescents Three to Seventeen Years of Age. Pediatric Infectious Disease Journal 31:5, pages 494-500.
Crossref
Crossref
Fangye Zhou, Jian Zhou, Lei Ma, Shaohui Song, Xinwen Zhang, Weidong Li, Shude Jiang, Yue Wang & Guoyang Liao. (2012) High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1. Biochemical and Biophysical Research Communications 421:4, pages 850-854.
Crossref
Crossref
H. J. Ehrlich, J. Singer, G. Berezuk, S. Fritsch, G. Aichinger, M. K. Hart, W. El-Amin, D. Portsmouth, O. Kistner & P. N. Barrett. (2012) A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals. Clinical Infectious Diseases 54:7, pages 946-954.
Crossref
Crossref
Ralf D. Hess, Friedemann Weber, Keith Watson & Siegfried Schmitt. (2012) Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines. Vaccine 30:17, pages 2715-2727.
Crossref
Crossref
Shin Murakami, Taisuke Horimoto, Mutsumi Ito, Ryo Takano, Hiroaki Katsura, Masayuki Shimojima & Yoshihiro Kawaoka. (2012) Enhanced Growth of Influenza Vaccine Seed Viruses in Vero Cells Mediated by Broadening the Optimal pH Range for Virus Membrane Fusion. Journal of Virology 86:3, pages 1405-1410.
Crossref
Crossref
Jyotsna Pandya, Rodion Gorchakov, Eryu Wang, Grace Leal & Scott C. Weaver. (2012) A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation. Vaccine 30:7, pages 1276-1282.
Crossref
Crossref
Yvonne E. Thomassen, Joyce E. van der Welle, Gerco van Eikenhorst, Leo A. van der Pol & Wilfried A.M. Bakker. (2012) Transfer of an adherent Vero cell culture method between two different rocking motion type bioreactors with respect to cell growth and metabolic rates. Process Biochemistry 47:2, pages 288-296.
Crossref
Crossref
Yo Han JangBaik-Lin Seong. (2012) Principles underlying rational design of live attenuated influenza vaccines. Clinical and Experimental Vaccine Research 1:1, pages 35.
Crossref
Crossref
Yvonne E. Thomassen, Gerco van Eikenhorst, Leo A. van der Pol & Wilfried A.M. Bakker. 2012. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009
723
727
.
Verena Lohr, Alexander Rath, Ingo Jordan, Volker Sandig, Yvonne Genzel & Udo Reichl. 2012. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009
615
631
.
Robert Schlegl & Rainer Hahn. 2012. Development of Novel Vaccines. Development of Novel Vaccines
145
188
.
Holger Loessner, Astrid Schwantes, Matthias Hamdorf, Uliana Komor, Sara Leschner & Siegfried Weiss. 2012. Development of Novel Vaccines. Development of Novel Vaccines
87
124
.
Emma Petiot, Danielle Jacob, Stephane Lanthier, Verena Lohr, Sven Ansorge & Amine A Kamen. (2011) Metabolic and Kinetic analyses of influenza production in perfusion HEK293 cell culture. BMC Biotechnology 11:1.
Crossref
Crossref
Elisabeth Roethl, Manuela Gassner, Brigitte M. Krenn, Ekaterina A. Romanovskaya-Romanko, Helena Seper, Julia Romanova, Sabine Nakowitsch, Sanda Sturlan, Markus Wolschek, Alexej Sirotkin, Oleg Kiselev, Thomas Muster & Andrej Egorov. (2011) Antimycotic-Antibiotic Amphotericin B Promotes Influenza Virus Replication in Cell Culture. Journal of Virology 85:21, pages 11139-11145.
Crossref
Crossref
Elisabeth Schuller, Anton Klingler, Katrin Dubischar-Kastner, Shailesh Dewasthaly & Zsuzsanna Müller. (2011) Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®. Vaccine 29:47, pages 8669-8676.
Crossref
Crossref
Yu-Fen Tseng, Alan Yung-Chih Hu, Mei-Liang Huang, Wei-Zhou Yeh, Tsai-Chuan Weng, Yu-Shuan Chen, Pele Chong & Min-Shi Lee. (2011) Adaptation of High-Growth Influenza H5N1 Vaccine Virus in Vero Cells: Implications for Pandemic Preparedness. PLoS ONE 6:10, pages e24057.
Crossref
Crossref
John Steel. (2012) New Strategies for the Development of H5N1 Subtype Influenza Vaccines. BioDrugs 25:5, pages 285-298.
Crossref
Crossref
S. V. Generalov, E. G. Abramova, A. K. Nikiforov & Zh. V. Matveeva. (2011) Cell Structures in Heterologous Anti-Rabies Immunoglobulin Production. Problems of Particularly Dangerous Infections:4(110), pages 76-79.
Crossref
Crossref
Jon Smith, Marc Lipsitch & Jeffrey W Almond. (2011) Vaccine production, distribution, access, and uptake. The Lancet 378:9789, pages 428-438.
Crossref
Crossref
Klaus K. Orlinger, Yvonne Hofmeister, Richard Fritz, Georg W. Holzer, Falko G. Falkner, Bernd Unger, Alexandra Loew-Baselli, Eva-Maria Poellabauer, Hartmut J. Ehrlich, P. Noel Barrett & Thomas R. Kreil. (2011) A Tick-borne Encephalitis Virus Vaccine Based on the European Prototype Strain Induces Broadly Reactive Cross-neutralizing Antibodies in Humans. The Journal of Infectious Diseases 203:11, pages 1556-1564.
Crossref
Crossref
Displaying 200 of 214 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list